Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
CGEN Stock Summary
Top 10 Correlated ETFs
CGEN
In the News
CGEN Financial details
Company Rating
Buy
Market Cap
190.7M
Income
-18.75M
Revenue
33.46M
Book val./share
0.74
Cash/share
0.58
Dividend
-
Dividend %
-
Employees
68
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-5.06
Forward P/E
-
PEG
1.16
P/S
21.32
P/B
3
P/C
3.3
P/FCF
-6.84
Quick Ratio
5.81
Current Ratio
5.81
Debt / Equity
0.02
LT Debt / Equity
0.01
-
-
EPS (TTM)
-0.22
EPS next Y
-
EPS next Q
-
EPS this Y
-46.15%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
-200%
-
-
-
-
SMA20
-33.33%
SMA50
-
SMA100
100%
Inst Own
10.68%
Inst Trans
0.81%
ROA
-47%
ROE
-48%
ROC
-0.6%
Gross Margin
87%
Oper. Margin
-460%
Profit Margin
-421%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.53-3.03
52W High
-
52W Low
-
RSI
33
Rel Volume
0.53
Avg Volume
626.13K
Volume
329.51K
Perf Week
-18.86%
Perf Month
-25.2%
Perf Quarter
162.69%
Perf Half Y
135.26%
-
-
-
-
Beta
2.679
-
-
Volatility
0.13%, 0.27%
Prev Close
-5.67%
Price
1.915
Change
-2.3%
CGEN Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-12-31
Metric | History | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0 | 0.03 | 0.07 | 0.09 | 0.38 | |
Net income per share | -0.43 | -0.34 | -0.39 | -0.39 | -0.21 | |
Operating cash flow per share | -0.44 | -0.36 | -0.27 | -0.4 | -0.41 | |
Free cash flow per share | -0.44 | -0.36 | -0.27 | -0.4 | -0.41 | |
Cash per share | 1.22 | 1.56 | 1.39 | 0.96 | 0.58 | |
Book value per share | 0.6 | 1.5 | 1.27 | 0.9 | 0.75 | |
Tangible book value per share | 0.6 | 1.5 | 1.27 | 0.9 | 0.75 | |
Share holders equity per share | 0.6 | 1.5 | 1.27 | 0.9 | 0.75 | |
Interest debt per share | 0.06 | 0.04 | 0.03 | 0.02 | 0.02 | |
Market cap | 379.27M | 963.85M | 362.08M | 61.95M | 175.27M | |
Enterprise value | 338.97M | 959.87M | 357.03M | 52.81M | 162.36M | |
P/E ratio | -13.87 | -35.36 | -11.01 | -1.84 | -9.35 | |
Price to sales ratio | 0 | 481.92 | 60.35 | 8.26 | 5.24 | |
POCF ratio | -13.6 | -34.03 | -15.92 | -1.8 | -4.87 | |
PFCF ratio | -13.52 | -33.84 | -15.71 | -1.77 | -4.85 | |
P/B Ratio | 9.9 | 8.05 | 3.39 | 0.8 | 2.67 | |
PTB ratio | 9.9 | 8.05 | 3.39 | 0.8 | 2.67 | |
EV to sales | 0 | 479.94 | 59.5 | 7.04 | 4.85 | |
Enterprise value over EBITDA | -11.74 | -30.48 | -10.18 | -1.49 | -12.97 | |
EV to operating cash flow | -12.15 | -33.89 | -15.69 | -1.53 | -4.51 | |
EV to free cash flow | -12.09 | -33.7 | -15.49 | -1.51 | -4.49 | |
Earnings yield | -0.07 | -0.03 | -0.09 | -0.54 | -0.11 | |
Free cash flow yield | -0.07 | -0.03 | -0.06 | -0.56 | -0.21 | |
Debt to equity | 0.09 | 0.03 | 0.03 | 0.02 | 0.02 | |
Debt to assets | 0.07 | 0.02 | 0.02 | 0.02 | 0.01 | |
Net debt to EBITDA | 1.4 | 0.13 | 0.14 | 0.26 | 1.03 | |
Current ratio | 6.6 | 12.27 | 7.21 | 7.23 | 4.36 | |
Interest coverage | -902.47 | -749.9 | -1.4K | -1.31K | -419.1 | |
Income quality | 1.02 | 0.95 | 0.67 | 1.02 | 1.92 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0 | 4.9 | 1.81 | 1.38 | 0.29 | |
Research and developement to revenue | 0 | 11.38 | 4.78 | 4.09 | 1.03 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.01 | 0.01 | 0.01 | 0.01 | 0 | |
Capex to revenue | 0 | -0.08 | -0.05 | -0.06 | -0.01 | |
Capex to depreciation | -0.16 | -0.23 | -0.63 | -1.01 | -0.36 | |
Stock based compensation to revenue | 0 | 1.39 | 0.71 | 0.58 | 0.11 | |
Graham number | 2.41 | 3.41 | 3.34 | 2.8 | 1.9 | |
ROIC | -0.62 | -0.23 | -0.3 | -0.43 | -0.37 | |
Return on tangible assets | -0.51 | -0.2 | -0.25 | -0.36 | -0.15 | |
Graham Net | 0.99 | 0.62 | 0.48 | 0.37 | 0.47 | |
Working capital | 38.18M | 118.57M | 106.13M | 74.21M | 88.31M | |
Tangible asset value | 38.32M | 119.78M | 106.69M | 77.68M | 65.56M | |
Net current asset value | 29.56M | 110.56M | 97.75M | 69.63M | 58.8M | |
Invested capital | 0.09 | 0.03 | 0.03 | 0.02 | 0.02 | |
Average receivables | 1.01M | 2.89M | 5.06M | 3.94M | 31.87M | |
Average payables | 2.02M | 1.25M | 3.02M | 3.2M | 2.64M | |
Average inventory | -1.06M | -60.03M | -114.63M | -91.31M | -36.32M | |
Days sales outstanding | 0 | 850.09 | 332.15 | 117.63 | 668.91 | |
Days payables outstanding | 401.54 | 8.6K | 2.48K | 663.74 | 515.42 | |
Days of inventory on hand | -287.87 | -725.67K | -59.02K | -27.2K | 0 | |
Receivables turnover | 0 | 0.43 | 1.1 | 3.1 | 0.55 | |
Payables turnover | 0.91 | 0.04 | 0.15 | 0.55 | 0.71 | |
Inventory turnover | -1.27 | 0 | -0.01 | -0.01 | 0 | |
ROE | -0.71 | -0.23 | -0.31 | -0.43 | -0.29 | |
Capex per share | 0 | 0 | 0 | -0.01 | 0 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.09 | 0 | 0 | 0 | 0.38 | |
Net income per share | -0.04 | -0.11 | -0.11 | -0.11 | 0.11 | |
Operating cash flow per share | -0.27 | 0 | 0 | 0 | 0 | |
Free cash flow per share | -0.27 | 0 | 0 | 0 | 0 | |
Cash per share | 0.96 | 0.86 | 0.76 | 0.65 | 0.58 | |
Book value per share | 0.9 | 0.8 | 0.71 | 0.6 | 0.74 | |
Tangible book value per share | 0.9 | 0.8 | 0.71 | 0.6 | 0.74 | |
Share holders equity per share | 0.9 | 0.8 | 0.71 | 0.6 | 0.74 | |
Interest debt per share | 0.03 | 0.01 | 0.02 | 0.02 | 0.02 | |
Market cap | 62M | 60.81M | 99.39M | 82.13M | 176.83M | |
Enterprise value | 52.86M | 64.39M | 39.01M | 35.76M | 163.93M | |
P/E ratio | -5.01 | -1.63 | -2.68 | -2.08 | 4.55 | |
Price to sales ratio | 8.27 | 0 | 0 | 0 | 5.28 | |
POCF ratio | -2.69 | 0 | 0 | 0 | 0 | |
PFCF ratio | -2.65 | 0 | 0 | 0 | 0 | |
P/B Ratio | 0.8 | 0.88 | 1.6 | 1.54 | 2.7 | |
PTB ratio | 0.8 | 0.88 | 1.6 | 1.54 | 2.7 | |
EV to sales | 7.05 | 0 | 0 | 0 | 4.9 | |
Enterprise value over EBITDA | -14.98 | -6.35 | -3.82 | -3.36 | 9.12 | |
EV to operating cash flow | -2.3 | 0 | 0 | 0 | 0 | |
EV to free cash flow | -2.26 | 0 | 0 | 0 | 0 | |
Earnings yield | -0.05 | -0.15 | -0.09 | -0.12 | 0.05 | |
Free cash flow yield | -0.38 | 0 | 0 | 0 | 0 | |
Debt to equity | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | |
Debt to assets | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | |
Net debt to EBITDA | 2.59 | -0.35 | 5.91 | 4.36 | -0.72 | |
Current ratio | 7.23 | 7.13 | 6.43 | 5.81 | 4.36 | |
Interest coverage | -7.13 | 12.54 | 0 | 0 | 0 | |
Income quality | 7.45 | 0 | 0 | 0 | 0 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.34 | 0 | 0 | 0 | 0.07 | |
Research and developement to revenue | 0.98 | 0 | 0 | 0 | 0.33 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.02 | 0 | 0 | 0 | 0 | |
Capex to revenue | -0.05 | 0 | 0 | 0 | 0 | |
Capex to depreciation | -6.5 | 0 | 0 | 0 | 0 | |
Stock based compensation to revenue | 0.58 | 0 | 0 | 0 | 0 | |
Graham number | 0.85 | 1.39 | 1.3 | 1.23 | 1.35 | |
ROIC | -0.04 | -0.14 | -0.16 | -0.19 | 0.14 | |
Return on tangible assets | -0.03 | -0.11 | -0.12 | -0.15 | 0.08 | |
Graham Net | 0.37 | 0.69 | 0.6 | 0.5 | 0.47 | |
Working capital | 74.21M | 65.72M | 58.6M | 49.89M | 88.31M | |
Tangible asset value | 77.68M | 69.21M | 62M | 53.23M | 65.56M | |
Net current asset value | 69.63M | 61.34M | 54.35M | 45.89M | 58.8M | |
Invested capital | 0.02 | 0.03 | 0.03 | 0.03 | 0.02 | |
Average receivables | 2.62M | 2.27M | 2.49M | 2.81M | 32.04M | |
Average payables | 7.15M | 5.94M | 5.89M | 5.73M | 6.64M | |
Average inventory | -37.74M | -37.39M | -2.49M | -2.81M | -1.38M | |
Days sales outstanding | 29 | 0 | 0 | 0 | 164.94 | |
Days payables outstanding | 163.66 | 0 | 0 | 0 | 157.28 | |
Days of inventory on hand | -6.71K | 0 | 0 | 0 | 0 | |
Receivables turnover | 3.1 | 0 | 0 | 0 | 0.55 | |
Payables turnover | 0.55 | 0 | 0 | 0 | 0.57 | |
Inventory turnover | -0.01 | 0 | 0 | 0 | 0 | |
ROE | -0.04 | -0.13 | -0.15 | -0.19 | 0.15 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
CGEN Frequently Asked Questions
What is Compugen Ltd. stock symbol ?
Compugen Ltd. is a IL stock and trading under the symbol CGEN
What is Compugen Ltd. stock quote today ?
Compugen Ltd. stock price is $1.915 today.
Is Compugen Ltd. stock public?
Yes, Compugen Ltd. is a publicly traded company.